The effect of losartan on cephalexin

2025-525059-23-00 Protocol T2025/25858 KEFALOS Human pharmacology (Phase I) - Other Ongoing, recruitment ended

Start 4 Mar 2026 · Status Ongoing, recruitment ended · 1 EU/EEA countries · 1 sites · Protocol T2025/25858 KEFALOS

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruitment ended
Participants planned 12
Countries 1
Sites 1

healthy volunteers

Key facts

Sponsor
Varsinais-Suomen hyvinvointialue
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Not possible to specify
Trial duration
4 Mar 2026 → ongoing
Decision date (initial)
2026-02-26
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2025-525059-23-00
ClinicalTrials.gov
NCT07300670

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

healthy volunteers

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Varsinais-Suomen hyvinvointialue

Sponsor organisation
Varsinais-Suomen hyvinvointialue
Address
Kiinamyllynkatu 4-8
City
Turku
Postcode
20520
Country
Finland

Scientific contact point

Organisation
Varsinais-Suomen hyvinvointialue
Contact name
Turku University Hospital, Unit of Clinical Pharmacology

Public contact point

Organisation
Varsinais-Suomen hyvinvointialue
Contact name
Turku University Hospital, Unit of Clinical Pharmacology

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Finland Ongoing, recruitment ended 12 1
Rest of world 0

Investigational sites

Finland

1 site · Ongoing, recruitment ended
Varsinais-Suomen hyvinvointialue
Turku University Hospital, Unit of Clinical Pharmacology, Kiinamyllynkatu 4-8, 20520, Turku

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Finland 2026-03-04 2026-03-04 2026-03-31

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2026-01-01 Finland Acceptable
2026-02-25
2026-02-26
2 NON SUBSTANTIAL MODIFICATION NSM-1 2026-04-14 Finland Acceptable
2026-02-25
2026-04-14